PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.44 - 1.45
1.18 - 2.36
61.0K / 1.73M (Avg.)
-18.00 | -0.08
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
120.68%
Some net income increase while 1097.HK is negative at -100.00%. John Neff would see a short-term edge over the struggling competitor.
-6.29%
Both reduce yoy D&A, with 1097.HK at -5.38%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
107.99%
Slight usage while 1097.HK is negative at -335.72%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
No Data
No Data available this quarter, please select a different quarter.
-65.41%
Both reduce yoy inventory, with 1097.HK at -97.04%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
No Data
No Data available this quarter, please select a different quarter.
106.84%
Some yoy usage while 1097.HK is negative at -415.44%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-6.24%
Negative yoy while 1097.HK is 1270.75%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
108.39%
Some CFO growth while 1097.HK is negative at -22.01%. John Neff would note a short-term liquidity lead over the competitor.
60.96%
CapEx growth well above 1097.HK's 12.49%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
-100.00%
Negative yoy acquisition while 1097.HK stands at 100.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
99.87%
Purchases growth of 99.87% while 1097.HK is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
6837.03%
Liquidation growth of 6837.03% while 1097.HK is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
81.42%
Less 'other investing' outflow yoy vs. 1097.HK's 189.12%. David Dodd would see a stronger short-term cash position unless competitor invests more wisely.
122.71%
Investing outflow well above 1097.HK's 15.09%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
11178.81%
Issuance growth of 11178.81% while 1097.HK is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
No Data
No Data available this quarter, please select a different quarter.